EyeTracking Packaging Study

Our research firm was retained by the company Amgen to asses the visual design of medical devices known as autoinjectors and their packaging. Autoinjectors are single-use, disposable medical devices that administer a fixed dose of drug product into subcutaneous tissue. Importantly, the carton and the internal packaging contain crucial instructions and precautions regarding the safe and effective way injections should be carried out. Our research team designed a test of different packaging configurations with the main aim of assessing if the design effected the way patients interacted with the packaging and could be correlated with their overall performance giving a self-injection.

Prototype Video USABILITY REPORT

PROJECT FEATURED

EmpATHIZE

DEFINE

IDEATE

PROTOTYPE

TEST

ROLES

Core Team:

Human factors engineers, research assistant, CEO of research firm

Business Stakeholders:

Amgen's human factors engineering devision

My Role:

Human factors engineer

My Duties:

Worked with stakeholders on study scope and design; managed recruitment and screening critera; managed laboratory data collection; set-up and calibrated eye-tracking equipment prior to each session; analyzed study data, created visualizations, and generated the research delieverables; presented final report to business stakeholders and top executives.

PROCESS

Discovery and Define Phase:

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Design, Development, and Test Phase:

OUTCOMES

The core team delivered the findings to key decision makers and design executives. A detailed elaboration of the insights and how the research effective overall business direction and strategy is confidential. However, the client retained the research firm for a multi-year contract to produce research that would aid the Amgen team with their goal of transitioning from a multi-step and potential dangerous syringe-based drug delivery system to a less complex, safer autojector system.